Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for...
Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes
About this item
Full title
Author / Creator
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
Hagerstown, MD: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
We evaluated differences in adherence and persistence with prescribed therapy of once-daily (OD) dosing compared with twice-daily (BID) dosing of glipizide in patients with type 2 diabetes.
The study cohort was derived from a pharmacy benefit manager claims database. Patients new to extended-release gastrointestinal therapeutic system (GITS) and...
Alternative Titles
Full title
Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71404761
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71404761
Other Identifiers
ISSN
0038-4348
DOI
10.1097/00007611-200201000-00014
